Hyaluronan (HA) and H11 Antigen (HABP) Expression in Cervical Cancer Sections and Their Significances as Prominent Markers

Manjunath Siddaiah, Geethe Avadni, Karuna Kumar Mortha

Abstract


This article has been retracted.

 

Background: Cancer is a disease characterized by a population of cells that grow and divide without respect to normal limits, invade and destroy adjacent tissues, and may spread to distant anatomic sites through a process called metastasis. These malignant properties of cancers differentiate them from benign tumors, which are self-limited in their growth and do not invade or metastasize for the development and progression of tumor cells. Cancer is a result of multistep process involving accumulation of genetic alternation, which results in loss of cell-cell interaction, increasing invasive migration, loss of control in cell division and abnormal matrix assembly. Carcinoma of the cervix is one of the most common malignancies. Cervical differentiation requires changes in the composition and structure of extracellular matrix. However, the biological roles of Hyaluronan (HA) in cervical remodeling are still under investigation and HA-receptors are not studied during cervical pathological remodeling. Hence, in the current study we investigated the expression and association of extracellular matrix components namely hyaluronan-hyaluronic acid binding protein (H11 antigen) (HA-HABP) in normal and invasive lesion in cervical tissue section slides.

Methods and Results: Cervical tissues from normal and suspected cancer patients from hospitals were examined. Immunohistochemistry was performed with specific HA probe, b. PG (biotinylated proteoglycan) and anti-HABP antibody H11B2C2 for H11 antigen. HA and H11 antigen are overexpressed in well-differentiated tumors during progression.

Conclusions: We conclude that the expression of HA and H11 antigen and their interaction are very important in identifying cervical cancers and probably H11 antigen can be used as a biomarker in identifying the tumor cells in cervical lesions.




doi:10.4021/wjon287e


Keywords


Cervical cancer section; Tumor; mAb H11B2C2; Hyaluronan (HA); Hyaluronic acid binding protein (HABP)

 

Browse  Journals  

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

World Journal of Oncology, bimonthly, ISSN 1920-4531 (print), 1920-454X (online), published by Elmer Press Inc.        
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.wjon.org   editorial contact: editor@wjon.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.